11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Melatonin and Health: Insights of Melatonin Action, Biological Functions, and Associated Disorders

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Melatonin is ubiquitous molecule with wide distribution in nature and is produced by many living organisms. In human beings, pineal gland is the major site for melatonin production and to lesser extent by retina, lymphocytes, bone marrow, gastrointestinal tract, and thymus. Melatonin as a neurohormone is released into circulation wherein it penetrates all tissues of the body. Melatonin synthesis and secretion is supressed by light and enhanced by dark. Melatonin mostly exerts its effect through different pathways with melatonin receptor 1 (MT1) and melatonin receptor 2 (MT2) being the predominant type of receptor that are mainly expressed by many mammalian organs. Melatonin helps to regulate sleep patterns and circadian rhythms. In addition, melatonin acts as an antioxidant and scavenges excessive free radicals generated in the body by anti-excitatory and anti-inflammatory properties. A multiple array of other functions are displayed by melatonin that include oncostatic, hypnotic, immune regulation, reproduction, puberty timing, mood disorders, and transplantation. Deficiencies in the production or synthesis of melatonin have been found to be associated with onset of many disorders like breast cancer and neurodegenerative disorders. Melatonin could be used as potential analgesic drug in diseases associated with pain and it has quite promising role there. In the past century, a growing interest has been developed regarding the wide use of melatonin in treating various diseases like inflammatory, gastrointestinal, cancer, mood disorders, and others. Several melatonin agonists have been synthesized and are widely used in disease treatment. In this review, an effort has been made to describe the biochemistry of melatonin along with its therapeutic potential in various diseases of humans.

          Graphical Abstract

          Related collections

          Most cited references273

          • Record: found
          • Abstract: not found
          • Article: not found

          Systemic lupus erythematosus.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            The Global Burden of Cancer 2013

            Cancer is among the leading causes of death worldwide. Current estimates of cancer burden in individual countries and regions are necessary to inform local cancer control strategies.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.

              Obesity is becoming a global epidemic in both children and adults. It is associated with numerous comorbidities such as cardiovascular diseases (CVD), type 2 diabetes, hypertension, certain cancers, and sleep apnea/sleep-disordered breathing. In fact, obesity is an independent risk factor for CVD, and CVD risks have also been documented in obese children. Obesity is associated with an increased risk of morbidity and mortality as well as reduced life expectancy. Health service use and medical costs associated with obesity and related diseases have risen dramatically and are expected to continue to rise. Besides an altered metabolic profile, a variety of adaptations/alterations in cardiac structure and function occur in the individual as adipose tissue accumulates in excess amounts, even in the absence of comorbidities. Hence, obesity may affect the heart through its influence on known risk factors such as dyslipidemia, hypertension, glucose intolerance, inflammatory markers, obstructive sleep apnea/hypoventilation, and the prothrombotic state, in addition to as-yet-unrecognized mechanisms. On the whole, overweight and obesity predispose to or are associated with numerous cardiac complications such as coronary heart disease, heart failure, and sudden death because of their impact on the cardiovascular system. The pathophysiology of these entities that are linked to obesity will be discussed. However, the cardiovascular clinical evaluation of obese patients may be limited because of the morphology of the individual. In this statement, we review the available evidence of the impact of obesity on CVD with emphasis on the evaluation of cardiac structure and function in obese patients and the effect of weight loss on the cardiovascular system.
                Bookmark

                Author and article information

                Contributors
                sbilal@skuastkashmir.ac.in
                draarif31@skuastkashmir.ac.in
                ishraq@skuastkashmir.ac.in
                mudasir@skuastkashmir.ac.in
                waniamir1647@skuastkashmir.ac.in
                rahilrazak789@skuastkashmir.ac.in
                mrehman1@ksu.edu.sa
                Journal
                Cell Mol Neurobiol
                Cell Mol Neurobiol
                Cellular and Molecular Neurobiology
                Springer US (New York )
                0272-4340
                1573-6830
                8 February 2023
                : 1-22
                Affiliations
                [1 ]GRID grid.444725.4, ISNI 0000 0004 0500 6225, Molecular Biology Lab, Division of Veterinary Biochemistry, F.V.Sc. & A. H. Shuhama, , Sher-e-Kashmir University of Agricultural Sciences and Technology-Kashmir, ; Shalimar, Srinagar, 190006 Jammu and Kashmir India
                [2 ]GRID grid.444725.4, ISNI 0000 0004 0500 6225, Division of Forest Biology and Tree Improvement, Faculty of Forestry, , Sher-e-Kashmir University of Agricultural Sciences and Technology-Kashmir, ; Benhama, Ganderbal, 191201 Jammu and Kashmir India
                [3 ]GRID grid.444725.4, ISNI 0000 0004 0500 6225, Division of Biotechnology, , Sher-e-Kashmir University of Agricultural Sciences and Technology-Kashmir, ; Srinagar, 190006 Jammu and Kashmir India
                [4 ]GRID grid.56302.32, ISNI 0000 0004 1773 5396, Department of Clinical Pharmacy, College of Pharmacy, , King Saud University, ; Riyadh, 11451 Saudi Arabia
                Author information
                http://orcid.org/0000-0002-6360-8457
                http://orcid.org/0000-0001-8789-2715
                http://orcid.org/0000-0002-1322-2054
                http://orcid.org/0000-0001-9987-5293
                http://orcid.org/0000-0001-6954-9729
                http://orcid.org/0000-0002-2243-8850
                http://orcid.org/0000-0002-9995-6576
                Article
                1324
                10.1007/s10571-023-01324-w
                9907215
                36752886
                4a6942bd-a546-49ba-ac74-92d95edec931
                © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

                This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.

                History
                : 20 November 2022
                : 26 January 2023
                Categories
                Review Paper

                Neurosciences
                melatonin,therapeutic,antioxidant,diseases,agonists
                Neurosciences
                melatonin, therapeutic, antioxidant, diseases, agonists

                Comments

                Comment on this article